Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

 Full screen view
Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
MZ7-mel Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 1.0000
uM
 72
hr
 1 1513 441 0.2825 0.2196 0.2915 0.2973
MZ7-mel Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 1.0000
uM
 72
hr
 2 1300 383 0.2417 0.2196 0.2946 0.2973
MZ7-mel Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 1.0000
uM
 72
hr
 3 736 225 0.1347 0.2196 0.3057 0.2973
MZ7-mel Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 3.1600
uM
 72
hr
 1 1218 410 0.2129 0.1903 0.3366 0.3372
MZ7-mel Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 3.1600
uM
 72
hr
 2 1243 391 0.2245 0.1903 0.3146 0.3372
MZ7-mel Vemurafenib Trametinib JNK-IN-8 0.3160 0.0316 3.1600
uM
 72
hr
 3 791 285 0.1334 0.1903 0.3603 0.3372
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.0000
uM
 72
hr
 1 1360 571 0.2079 0.2508 0.4199 0.4127
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.0000
uM
 72
hr
 2 1754 649 0.2912 0.2508 0.3700 0.4127
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.0000
uM
 72
hr
 3 1742 781 0.2533 0.2508 0.4483 0.4127
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.3160
uM
 72
hr
 1 1289 485 0.2119 0.2132 0.3763 0.3794
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.3160
uM
 72
hr
 2 1220 456 0.2014 0.2132 0.3738 0.3794
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 0.3160
uM
 72
hr
 3 1404 545 0.2264 0.2132 0.3882 0.3794
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 1.0000
uM
 72
hr
 1 1664 648 0.2678 0.2084 0.3894 0.3793
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 1.0000
uM
 72
hr
 2 1379 496 0.2327 0.2084 0.3597 0.3793
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 1.0000
uM
 72
hr
 3 774 301 0.1247 0.2084 0.3889 0.3793
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 3.1600
uM
 72
hr
 1 1131 440 0.1821 0.1620 0.3890 0.3871
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 3.1600
uM
 72
hr
 2 1151 434 0.1890 0.1620 0.3771 0.3871
MZ7-mel Vemurafenib Trametinib JNK-IN-8 1.0000 0.1000 3.1600
uM
 72
hr
 3 721 285 0.1149 0.1620 0.3953 0.3871
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.0000
uM
 72
hr
 1 1381 756 0.1647 0.1960 0.5474 0.5353
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.0000
uM
 72
hr
 2 1725 939 0.2072 0.1960 0.5443 0.5353
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.0000
uM
 72
hr
 3 1688 868 0.2161 0.1960 0.5142 0.5353
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.3160
uM
 72
hr
 1 728 351 0.0994 0.1052 0.4821 0.4516
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.3160
uM
 72
hr
 2 716 324 0.1033 0.1052 0.4525 0.4516
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 0.3160
uM
 72
hr
 3 738 310 0.1128 0.1052 0.4201 0.4516
MZ7-mel Vemurafenib Trametinib JNK-IN-8 3.1600 0.3160 1.0000
uM
 72
hr
 1 1588 728 0.2267 0.1575 0.4584 0.4835